Susquehanna International Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,400
Closed -$400K 13596
2025
Q2
$400K Buy
+17,400
New +$403K ﹤0.01% 9683
2024
Q2
Sell
-48,400
Closed -$948K 12981
2024
Q1
$948K Buy
48,400
+39,000
+415% +$824K ﹤0.01% 7048
2023
Q4
$216K Buy
+9,400
New +$210K ﹤0.01% 10516
2023
Q3
Sell
-12,000
Closed -$313K 12764
2023
Q2
$313K Buy
+12,000
New +$317K ﹤0.01% 9342
2023
Q1
Sell
-112,300
Closed -$2.55M 13281
2022
Q4
$2.55M Buy
112,300
+67,800
+152% +$1.89M ﹤0.01% 4280
2022
Q3
$1.52M Sell
44,500
-117,000
-72% -$4.33M ﹤0.01% 5578
2022
Q2
$4.7M Buy
161,500
+128,500
+389% +$3.27M ﹤0.01% 3284
2022
Q1
$882K Buy
+33,000
New +$779K ﹤0.01% 7450

Other funds holding PRVA

Susquehanna International Group's PRVA Position: Q1 2026 in Review

Susquehanna International Group increased its Privia Health (PRVA) stake by 185% in Q1 2026, buying an estimated $571K and bringing the position to 39,003 shares worth $802K. The position accounts for ﹤0.01% of the portfolio, ranked #8465.

Susquehanna International Group first reported a position in PRVA in Q1 2022 and has held it in 14 quarters since. The position peaked at $4.83M in Q2 2023. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Susquehanna International Group held 39,003 shares of Privia Health worth $802K as of Q1 2026.
  • Susquehanna International Group bought 25,337 Privia Health shares in Q1 2026, an estimated $571K.
  • Privia Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8465 holding.
  • Susquehanna International Group first reported a position in Privia Health in Q1 2022 and has held it in 14 quarters since.
  • Susquehanna International Group's Privia Health position peaked at $4.83M in Q2 2023.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.